BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Kui Yang, Ruoyu Guan, Chenghong Peng. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trialsScandinavian Journal of Gastroenterology 2016; 51(12): 1512 doi: 10.1080/00365521.2016.1216588
2
Laura Kulik, Julie K. Heimbach, Feras Zaiem, Jehad Almasri, Larry J Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysisHepatology 2018; 67(1): 381 doi: 10.1002/hep.29485
3
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populationsRadiology of Infectious Diseases 2015; 2(2): 109 doi: 10.1016/j.jrid.2015.07.002
4
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survivalWorld Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
5
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen, Chenghong Peng. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysisJournal of Gastroenterology and Hepatology 2017; 32(7): 1286 doi: 10.1111/jgh.13727
6
Li Shen, Guangshun Zhang, Zhaohuan Lou, Guanhua Xu, Guangji Zhang. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivoBMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1548-4
7
Cheng-Shi Chen, Fang-Kun Li, Chen-Yang Guo, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Lin Zheng, Deng-Wei Zong, Jun-Li Ma, Li Jiang, Hai-Liang Li. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolizationOncotarget 2016; 7(6): 7241 doi: 10.18632/oncotarget.6892
8
Gustavo Pilotto Domingues Sá, Jorge Roberto Marcante Carlotto, Fernando Pompeu Piza Vicentine, Luiz Romero, Dario Fernandes Perdomo Tejada, Alcides Augusto Salzedas Netto, Gaspar de Jesus Lopes Filho, Adriano Miziara Gonzalez. Avaliação do tratamento dos nódulos do hepatocarcinoma nos pacientes em lista de espera para transplante hepáticoRevista do Colégio Brasileiro de Cirurgiões 2017; 44(4): 360 doi: 10.1590/0100-69912017004010
9
Sanchari Bhattacharya, Laboni Mondal, Biswajit Mukherjee, Lopamudra Dutta, Iman Ehsan, Mita C. Debnath, Raghuvir H. Gaonkar, Murari M. Pal, Subrata Majumdar. Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in ratsNanomedicine: Nanotechnology, Biology and Medicine 2018; 14(6): 1905 doi: 10.1016/j.nano.2018.05.011
10
Experimental and Clinical Transplantation 2018;  doi: 10.6002/ect.2018.0017